U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H16N8OS
Molecular Weight 392.438
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Tebapivat

SMILES

CN1C2=C(SC(CC3=NNC=C3)=N2)C4=C1C(=O)N(CC5=CC=CC(N)=N5)N=C4

InChI

InChIKey=DIUOELXIXSCFCR-UHFFFAOYSA-N
InChI=1S/C18H16N8OS/c1-25-15-12(16-17(25)23-14(28-16)7-10-5-6-20-24-10)8-21-26(18(15)27)9-11-3-2-4-13(19)22-11/h2-6,8H,7,9H2,1H3,(H2,19,22)(H,20,24)

HIDE SMILES / InChI

Molecular Formula C18H16N8OS
Molecular Weight 392.438
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
38.2 ng/mL
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TEBAPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
89.025 ng/mL
5 mg 1 times / day multiple, oral
dose: 5 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TEBAPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
143.9 ng × h/mL
5 mg single, oral
dose: 5 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
TEBAPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
542.4 ng × h/mL
5 mg 1 times / day multiple, oral
dose: 5 mg
route of administration: Oral
experiment type: MULTIPLE
co-administered:
TEBAPIVAT plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Substance Class Chemical
Created
by admin
on Wed Apr 02 06:14:07 GMT 2025
Edited
by admin
on Wed Apr 02 06:14:07 GMT 2025
Record UNII
ORG4KGP5ZS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Tebapivat
INN   USAN  
Official Name English
5H-Thiazolo[5?,4?:4,5]pyrrolo[2,3-d]pyridazin-5-one, 6-[(6-amino-2-pyridinyl)methyl]-4,6-dihydro-4-methyl-2-(1H-pyrazol-3-ylmethyl)-
Preferred Name English
6-[(6-Amino-2-pyridinyl)methyl]-4,6-dihydro-4-methyl-2-(1H-pyrazol-3-ylmethyl)-5H-thiazolo[5?,4?:4,5]pyrrolo[2,3-d]pyridazin-5-one
Systematic Name English
TEBAPIVAT [USAN]
Common Name English
AG-946
Common Name English
AGI-44416
Common Name English
2-((1H-pyrazol-3-yl)methyl)-6-((6-aminopyridin-2-yl)methyl)-4-methyl-4H-thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5(6H)-one
Systematic Name English
tebapivat [INN]
Common Name English
Code System Code Type Description
PUBCHEM
137501615
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
USAN
MN-276
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
SMS_ID
300000032598
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
FDA UNII
ORG4KGP5ZS
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
INN
12719
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
NCI_THESAURUS
C203234
Created by admin on Wed Apr 02 06:14:07 GMT 2025 , Edited by admin on Wed Apr 02 06:14:07 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY